Patents by Inventor Hsi Chung Fusselman

Hsi Chung Fusselman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11207463
    Abstract: Apparatuses and methods for identifying an infusate in a reservoir of an infusion device and systems for use in filling fluid delivery devices are provided. An exemplary apparatus for identifying an infusate in a reservoir of an infusion device includes a chamber in selective fluid communication with the reservoir. Further, the apparatus includes an indicator located in the chamber. The indicator exhibits a visual change when contacted by an infusate. The apparatus also includes a detector arrangement to identify the infusate by detecting the visual change in the indicator. An exemplary detector arrangement may include a camera to capture an image of the infusate and indicator in the chamber, and an identifier element to compare image data to a library of stored image data.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: December 28, 2021
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Afshin Bazargan, Sarnath Chattaraj, Hsi Chung Fusselman, Guangping Zhang, Jinghua Chen
  • Publication number: 20200138852
    Abstract: Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated with the treatment of the diabetic patient where the treatment requires subcutaneous implantation of a foreign body, such as a cannula or catheter. In certain embodiments of the invention, a response-inhibiting agent is administered to a patient at the site of cannula/catheter insertion, thereby facilitating delivery of insulin to the diabetic patient and mitigating site-loss and/or occlusion over a period of time.
    Type: Application
    Filed: November 22, 2019
    Publication date: May 7, 2020
    Applicant: Medtronic MiniMed, Inc.
    Inventors: Sarnath Chattaraj, Kiem H. Dang, Hsi Chung Fusselman, Poonam S. Gulati, Lance P. Hoffman, Guangping Zhang
  • Patent number: 10517892
    Abstract: Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated with the treatment of the diabetic patient where the treatment requires subcutaneous implantation of a foreign body, such as a cannula or catheter. In certain embodiments of the invention, a response-inhibiting agent is administered to a patient at the site of cannula/catheter insertion, thereby facilitating delivery of insulin to the diabetic patient and mitigating site-loss and/or occlusion over a period of time.
    Type: Grant
    Filed: October 13, 2014
    Date of Patent: December 31, 2019
    Assignee: MEDTRONIC MINIMED, INC.
    Inventors: Sarnath Chattaraj, Kiem H. Dang, Hsi Chung Fusselman, Poonam S. Gulati, Lance P. Hoffman, Guangping Zhang
  • Publication number: 20180240236
    Abstract: Apparatuses and methods for identifying an infusate in a reservoir of an infusion device and systems for use in filling fluid delivery devices are provided. An exemplary apparatus for identifying an infusate in a reservoir of an infusion device includes a chamber in selective fluid communication with the reservoir. Further, the apparatus includes an indicator located in the chamber. The indicator exhibits a visual change when contacted by an infusate. The apparatus also includes a detector arrangement to identify the infusate by detecting the visual change in the indicator. An exemplary detector arrangement may include a camera to capture an image of the infusate and indicator in the chamber, and an identifier element to compare image data to a library of stored image data.
    Type: Application
    Filed: February 21, 2017
    Publication date: August 23, 2018
    Inventors: Afshin Bazargan, Sarnath Chattaraj, Hsi Chung Fusselman, Guangping Zhang, Jinghua Chen
  • Publication number: 20150112302
    Abstract: Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated with the treatment of the diabetic patient where the treatment requires subcutaneous implantation of a foreign body, such as a cannula or catheter. In certain embodiments of the invention, a response-inhibiting agent is administered to a patient at the site of cannula/catheter insertion, thereby facilitating delivery of insulin to the diabetic patient and mitigating site-loss and/or occlusion over a period of time.
    Type: Application
    Filed: October 13, 2014
    Publication date: April 23, 2015
    Inventors: Sarnath Chattaraj, Kiem H. Dang, Hsi Chung Fusselman, Poonam S. Gulati, Lance P. Hoffman, Guangping Zhang